Jim Simons’s ImageneBio Inc IMA Stock Holding History

Jim Simons’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$513K	Buy	86,930 +5,234	+6%	+$29.6K	﹤0.01%	2603
2026 Q1	$408K	Buy	81,696 +15,600	+24%	+$101K	﹤0.01%	2683
2025 Q4	$456K	Buy	66,096 +28,718	+77%	+$213K	﹤0.01%	2609
2025 Q3	$305K	Buy	37,378 +11,640	+45%	+$154K	﹤0.01%	2987
2025 Q2	$414K	Buy	25,738 +1,197	+5%	+$17.6K	﹤0.01%	2929
2025 Q1	$377K	Sell	24,541 -2,976	-11%	-$51.3K	﹤0.01%	2844
2024 Q4	$542K	Sell	27,517 -5,866	-18%	-$119K	﹤0.01%	2806
2024 Q3	$693K	Sell	33,383 -6,317	-16%	-$128K	﹤0.01%	2640
2024 Q2	$786K	Sell	39,700 -25,017	-39%	-$442K	﹤0.01%	2456
2024 Q1	$1.1M	Buy	+64,717	New	+$1.18M	﹤0.01%	2429
2023 Q4	–	Sell	-1,091	Closed	-$57K	–	3898
2023 Q3	$57K	Sell	1,091 -84	-7%	-$5.06K	﹤0.01%	3379
2023 Q2	$92K	Buy	+1,175	New	+$84.3K	﹤0.01%	3496

Other funds holding IMA

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Jim Simons's IMA Position: Q2 2026 in Review

Jim Simons increased its ImageneBio Inc (IMA) stake by 6.4% in Q2 2026, buying an estimated $29.6K and bringing the position to 86,930 shares worth $513K. The position accounts for ﹤0.01% of the portfolio, ranked #2603.

Jim Simons first reported a position in IMA in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.1M in Q1 2024. 35 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

Jim Simons held 86,930 shares of ImageneBio Inc worth $513K as of Q2 2026.
Jim Simons bought 5,234 ImageneBio Inc shares in Q2 2026, an estimated $29.6K.
ImageneBio Inc made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #2603 holding.
Jim Simons first reported a position in ImageneBio Inc in Q2 2023 and has held it in 12 quarters since.
Jim Simons's ImageneBio Inc position peaked at $1.1M in Q1 2024.
35 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.